Cargando…
Correlation of cancer antigen 15-3 (CA15-3) serum level and bony metastases in breast cancer patients
Background: Cancer antigen 15-3 (CA15-3) is a common tumor marker and the serum level of this tumor marker is evaluated during the treatment period (periodically) in breast cancer patients. Assuming that the elevated serum levels of this tumor marker can be a potential risk, this study was conducted...
Autores principales: | Fakhari, Ashraf, Gharepapagh, Esmaeil, Dabiri, Shahram, Gilani, Neda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iran University of Medical Sciences
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137849/ https://www.ncbi.nlm.nih.gov/pubmed/32280648 http://dx.doi.org/10.34171/mjiri.33.142 |
Ejemplares similares
-
Use of
(99m)
Tc-DTPA Scintigraphy in Evaluation of Ureteral Laceration Due to Transurethral Lithotripsy in a Patient with Nephrolithiasis
por: Gharepapagh, Esmaeil, et al.
Publicado: (2022) -
Prognostic Impact of Elevation of Cancer Antigen 15-3 (CA15-3) in Patients With Early Breast Cancer With Normal Serum CA15-3 Level
por: Ryu, Jai Min, et al.
Publicado: (2023) -
Comparison of mammary serum antigen (MSA) and CA15-3 levels in the serum of patients with breast cancer.
por: Sacks, N. P., et al.
Publicado: (1987) -
Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance
por: Hing, J.X., et al.
Publicado: (2020) -
Lectin nanoparticle assays for detecting breast cancer-associated glycovariants of cancer antigen 15-3 (CA15-3) in human plasma
por: Terävä, Joonas, et al.
Publicado: (2019)